Outcome Analysis of Endoscopic Resection of Pituitary Adenomas
Launched by NATIONAL CHENG-KUNG UNIVERSITY HOSPITAL · Nov 24, 2023
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding the outcomes for patients who have a specific type of brain tumor called a pituitary adenoma and have undergone a surgical procedure known as endoscopic resection. This means that doctors are using a small camera and special tools inserted through the nose to remove the tumor. The study aims to find out how patients do after this surgery, looking at various factors like their vision, hormone levels, overall survival, and daily functioning.
To participate in this trial, you need to be an adult between the ages of 18 and 80 who has been diagnosed with a pituitary adenoma and has had the endoscopic surgery. Unfortunately, if you have another type of tumor or if your surgery was done using a different method, you wouldn't be eligible. During the study, your medical history and test results will be collected and reviewed to help the researchers understand the surgery's effects better. If you qualify, you'll be contributing to important research that could help many others in the future!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patient
- • Pathological diagnosis of pituitary adenoma
- • Underwent endoscopic endonasal resection
- Exclusion Criteria:
- • Age \< 18 or \> 80 years
- • Non-pituitary adenoma pathologies
- • Underwent non-endoscopic surgery
About National Cheng Kung University Hospital
National Cheng Kung University Hospital is a leading academic medical institution in Taiwan, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its extensive resources and expertise in various medical fields to facilitate groundbreaking studies that enhance patient care and medical knowledge. Committed to adhering to the highest ethical standards and regulatory guidelines, National Cheng Kung University Hospital fosters collaborations with researchers, healthcare professionals, and industry partners to drive the development of new therapies and improve health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tainan, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported